<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>583</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15157087</PubmedId>
            <Abstract>The erythrocyte binding antigen EBA-175 is a 175-kDa Plasmodium falciparum protein, which has been shown to be involved in the process of invasion of erythrocytes. It has been found that conserved peptide 1818 belonging to this protein has high red blood cell binding capacity and plays an important role in the invasion process. This peptide is neither immunogenic nor protective. Peptide 1818 analogues had some of their previously recognized critical red blood cell binding residues substituted for amino acids having similar volume or mass but different polarity to make them fit into HLA-DRbeta(1)*1101 molecules; these 1818 peptide analogues were then synthesized and inoculated into Aotus nancymaae monkeys, generating different immunogenic and/or protective immune responses. Short structures such as 3(10)-helix, classical, or distorted type-III beta-turns were found in the immunogenic and protective peptides once the secondary structure had been analyzed by NMR and its structure correlated with its immunological properties. These data suggest that peptide flexibility may lead to better fitting into immune system molecules, therefore making them excellent candidates for consideration as components of a subunit-based, multicomponent synthetic antimalarial vaccine.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>6545-53</ArticlePages>
            <ArticleTitle>Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Cifuentes</LastName>
                    <ForeName>Gladys</ForeName>
                </Author>
                <Author>
                    <LastName>Espejo</LastName>
                    <ForeName>Fabiola</ForeName>
                </Author>
                <Author>
                    <LastName>Vargas</LastName>
                    <ForeName>Luis Eduardo</ForeName>
                </Author>
                <Author>
                    <LastName>Parra</LastName>
                    <ForeName>Carlos</ForeName>
                </Author>
                <Author>
                    <LastName>Vanegas</LastName>
                    <ForeName>Magnolia</ForeName>
                </Author>
                <Author>
                    <LastName>Patarroyo</LastName>
                    <ForeName>Manuel Elkin</ForeName>
                </Author>
            </Authors>
            <Affiliations>Fundación Instituto de Inmunología de Colombia, Carrera 50 N. 26-00 Bogotá 020304 Colombia.</Affiliations>
            <ArticleChemicalList>Antigens, Protozoan;Carrier Proteins;HLA-DR Antigens;HLA-DRB1 Chains;Histocompatibility Antigens Class II;Macromolecular Substances;Malaria Vaccines;Peptide Fragments;Protozoan Proteins;Receptors, Antigen, T-Cell;Vaccines, Synthetic;erythrocyte-binding antigen 175, Plasmodium</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Protozoan; Aotidae; Binding Sites; Carrier Proteins(chemistry); HLA-DR Antigens(metabolism); HLA-DRB1 Chains; Histocompatibility Antigens Class II(metabolism); Humans; Macromolecular Substances; Magnetic Resonance Spectroscopy; Malaria(immunology; prevention &amp; control); Malaria Vaccines(immunology); Models, Molecular; Molecular Sequence Data; Peptide Fragments(chemistry; immunology; metabolism); Protein Conformation; Protozoan Proteins(chemistry); Receptors, Antigen, T-Cell(metabolism); Vaccines, Synthetic(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>43</Volume>
                <Issue>21</Issue>
                <Title>Biochemistry</Title>
                <Issn>0006-2960</Issn>
                <MedlineTa>Biochemistry</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>24166</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>FNNIPSRYNLYDKMLPLDD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>17210</EpitopeId>
                <ReferenceStartingPosition>1283</ReferenceStartingPosition>
                <ReferenceEndingPosition>1301</ReferenceEndingPosition>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5226</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5228</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>69.0</QuantitativeMeasurement>
                            <AssayComments>&gt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5225</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>45.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5227</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>22690</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>NNIPSRYNLYDKMLDLD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45133</EpitopeId>
                <ReferenceStartingPosition>1284</ReferenceStartingPosition>
                <ReferenceEndingPosition>1300</ReferenceEndingPosition>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5230</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5229</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5232</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>24.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5231</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>13.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>23390</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>NNIPSRYNLYDKMLDLDDL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45134</EpitopeId>
                <ReferenceStartingPosition>1284</ReferenceStartingPosition>
                <ReferenceEndingPosition>1302</ReferenceEndingPosition>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5235</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>15.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5234</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>52.0</QuantitativeMeasurement>
                            <AssayComments>&gt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5236</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>24.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5233</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>23762</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>NNIPSRYNLYDKMLPLDL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45135</EpitopeId>
                <ReferenceStartingPosition>1284</ReferenceStartingPosition>
                <ReferenceEndingPosition>1301</ReferenceEndingPosition>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5237</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>27.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5240</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>29.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5238</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>29.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5239</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>27608</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>FNNIPSRYNLYDKMLELDD</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>17209</EpitopeId>
                <ReferenceStartingPosition>1283</ReferenceStartingPosition>
                <ReferenceEndingPosition>1301</ReferenceEndingPosition>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5242</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>63.0</QuantitativeMeasurement>
                            <AssayComments>&gt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5243</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>23.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5241</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>38.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>5244</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>24.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>1818</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NNNFNNIPSRYNLYDKKLDL</LinearSequence>
                        <StartingPosition>1280</StartingPosition>
                        <EndingPosition>1299</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19214.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45186</EpitopeId>
                <ReferenceStartingPosition>1280</ReferenceStartingPosition>
                <ReferenceEndingPosition>1299</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a modified analog of peptide 1818 from P. falciparum.  The authors report humoral responses for this epitope.  However, these responses have not been documented herein as the MHC binding studies are done with purified HLA, while the humoral responses are reported in monkeys which express a homologous molecule.".</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>7218</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>33.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>57</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>7217</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>52</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>7219</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>11.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>63</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>7220</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>295</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>6.0</QuantitativeMeasurement>
                            <AssayComments>&lt;50.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>419</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

